Sphenopalatine and occipital nerve blocks for chronic migraine
Keywords:
Chronic Migraine, Anesthetic blockAbstract
Title: Sphenopalatine and occipital nerve blocks for chronic migraine
Introduction
Headache is one of the most prevalent conditions in medicine, with migraine being the most common representative of primary headaches. Although it doesn't lead to high mortality, it carries with it great potential for incapacitation The therapeutic arsenal includes various classes of drugs, but when these drugs prove ineffective or are not tolerated, there is a need for other forms of treatment. Evaluating the functional anatomy of the sensory systems related to headache, sensory afferents are not only the result of the occipital nerves, but also of the trigemino-vascular system, represented by the sphenopalatine ganglion. These structures present a functional convergence, carrying sensory afferents and contributing to the phenomenon of sensitization.This model served as the basis for developing a protocol to block these fundamental structures in the pathophysiology of headache.
Objectives
To evaluate the therapeutic response to serial blockade of the sphenopalatine ganglion and the greater and lesser occipital nerves in patients with chronic migraine at the headache clinic at HC UFPR. Quantifying the response after the blocks, assessing intensity, frequency of pain crises and adverse effects.
Methods
Blockades of the sphenopalatine ganglion and the greater and lesser occipital nerves. The solution used contained 0.2% Ropivacaine with 45mcg Clonidine, 2ml of which was applied bilaterally to the region adjacent to each occipital nerve, and 12ml of which was slowly instilled in gauze inserted with forceps into the lower nasal meatus bilaterally. These procedures were to be carried out five times in series.
Results
The blocks were performed on 21 patients with chronic migraine at the headache clinic of the HC UFPR after consent. The majority were female, with a higher proportion aged between 48 and 62.
After a series of 5 blocks, satisfactory results were seen in more than 60% of the sample. Adverse effects were rare, with dizziness being the most frequently reported, leading to discontinuation in only 1 patient.
Conclusion
The results were promising in terms of pain control and a low level of adverse effects, suggesting that the procedure was safe. Further studies should be carried out to assess the effectiveness and level of sustained improvement over time.
Downloads
References
Referências:
Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24(Suppl. 1):1-160.
Maizels M, Geiger AM. Intranasal lidocaine for migraine: A randomized trial and open-label followup. Headache. 1999;39:543-551.
Candido KD, Massey ST, Sauer R, Darabad RR, Knezevic NN. A novel revision to the classical transnasal topical sphenopalatine ganglion block for the treatment of headache and facial pain. Pain Physician. 2013;16:E769-E778.
Yang I, Oraee S. A novel approach to transnasal sphenopalatine ganglion injection. Pain Physician. 2006;9:131-134.
Matthew S. Robbins, MD, et al. The Sphenopalatine ganglion: Anatomy, pathophysiology, and therapeutic targeting in headache. American Headache Society. Headache 2016;56:240-258
Fernandes L, et al. Peripheral nerve blocks for headache disorders. Pract Neurol 2021;21:30–35
Tassorelli C, et al. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. Cephalalgia 2018, Vol. 38(5) 815–832
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 João Vitor Mortari Lisboa, Alberto David Fadul Filho, Andresa Braga Baiak , Alexandre Teodoro Döhler Beck, Pedro André Kowacs, Larissa Souza Borowski Mendes, Ivo José Monteiro Marchioro (Author)
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.